Twenty Percent of Eligible Youth Prescribed GLP-1 Receptor Agonists

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on March 4, 2026.

via HealthDay

WEDNESDAY, March 4, 2026 -- Twenty percent of potentially eligible youth are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), with the odds of prescription higher with increasing age, increasing body mass index (BMI), and non-Hispanic White or Hispanic race and ethnicity, according to a study published online March 2 in Pediatrics.

Emily F. Gregory, M.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues conducted a retrospective cohort study involving youth aged 12 to 17 years with BMI ≥95th percentile for age and sex. GLP-1 RA prescription patterns and barriers to treatment were described.

The researchers found that 325 of the 1,647 youth (20 percent) had one or more GLP-1 RA prescriptions. With increasing age, increasing BMI, abnormal laboratory testing results, and non-Hispanic White or Hispanic race and ethnicity (versus non-Hispanic Black), the odds of prescription increased. On chart review of 102 youth with GLP-1 RA prescriptions, 65 youth (64 percent) experienced GLP-1 RA interruptions, most often related to cost and insurance coverage.

"We found that GLP-1 RAs prescribing was modest compared to potential eligibility in our network and focused on older youth with more severe obesity and more comorbidities," the authors write. "Even among youth prescribed GLP-1 RAs, multiple factors interfered with efficient achievement and maintenance of treatment."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-05 01:43

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords